Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Should Amedisys Inc (AMED) & Almost Family Inc (AFAM) Consider a Merger as North Tide Capital Suggests?

North Tide Capital, a hedge fund managed by Conan Laughlin, has issued a letter sent to the board of directors of Amedisys Inc (NASDAQ:AMED) suggesting that the company should consider a merger with Almost Family Inc (NASDAQ:AFAM). The fund owns shares of both companies; its stake in Amedisys contains 4.0 million shares, which represent 12% of the company’s stock and in Almost Family it owns an 11.5% position, which amasses 1.09 million shares.

Amedisys Inc

According to the investor a potential merger would provide more value creation opportunities for both companies and, respectively, for their shareholders. Among the reasons for the deal, North Tide mentioned that a merger would help Amedisys Inc (NASDAQ:AMED) to sole its corporate overhead inefficiencies and it will improve the market density and competitive positionining in several overlapping geographies. In addition, since Amedisys is currently looking for a new CEO, the chief executive of Almost Family Inc (NASDAQ:AFAM) William Yarmuth and President Steven Guenthner are two suitable candidates for this position. The deal can be also supported by the majority of shareholders of both companies, since, according to North Tide there is a more than 60% overlap that would facilitate the transaction.

Both Amedisys Inc (NASDAQ:AMED) and Almost Family are two healthcare companies engaged in home healthcare service, whose stocks spiked amid North Tide disclosing its letter. The fund is the largest shareholder of Amedisys Inc (NASDAQ:AMED) among the funds that we track, being followed by  James H. Litinsky‘s JHL Capital Group, which disclosed holding 905,000 shares in its latest 13F filing. Moreover, Israel Englander‘s Millennium Management has been bullish on the stock during the third quarter as it raised its exposure by 2,800% to 423,100 shares. North Tide is also the largest shareholder of Almost Family Inc (NASDAQ:AFAM), being followed by Kevin Kotler‘s Broadfin Capital, which initiated a stake during the third quarter with 224,200 shares.

North Tide is a healthcare-oriented hedge fund with an equity portfolio worth around $1.30 billion. North Tide has been a long-term shareholder of both companies and has held shares of Amedisys Inc (NASDAQ:AMED) since 2011 and Almost Family Inc (NASDAQ:AFAM) since 2012. But the investor consders that the industry needs to consolidate, which is why a merger could benefit both companies.

Disclosure: none

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!